ProAssurance (PRA)
(Delayed Data from NYSE)
$13.91 USD
+0.34 (2.51%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $13.93 +0.02 (0.14%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.91 USD
+0.34 (2.51%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $13.93 +0.02 (0.14%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth C Momentum F VGM
Zacks News
The Zacks Analyst Blog Highlights: Athene Holdings, ProAssurance Corp and Fidelity National Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Athene Holdings, ProAssurance Corp and Fidelity National Financial
3 Insurance Stocks That Have Outperformed S&P 500 YTD
by Tanuka De
Insurers Athene (ATH), ProAssurance (PRA) and Fidelity National (FNF) have outperformed the industry, the sector and the S&P 500 composite year to date and are poised to retain the rally given solid prospects.
Why Should You Add ProAssurance (PRA) to Your Portfolio?
by Zacks Equity Research
Riding on inorganic growth and cost-curbing measures, ProAssurance (PRA) holds the potential to reap benefits for investors.
Allstate (ALL) on Track to Sell Property to Reduce Expenses
by Zacks Equity Research
Allstate (ALL) to divest part of its Northbrook, IL property to warehouse builder Dermody Properties to cut down on expenses.
Why Should You Hold Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on inorganic growth measures and disciplined capital management, Marsh & McLennan (MMC) holds enough potential to reap benefits to investors.
ProAssurance's (PRA) Q3 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
ProAssurance's (PRA) Q3 results reflect better premiums, lower expenses and a strong contribution from the Specialty P&C Insurance and Corporate segments.
ProAssurance (PRA) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
ProAssurance (PRA) delivered earnings and revenue surprises of 66.67% and 8.87%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
ProAssurance (PRA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
ProAssurance (PRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for W. R. Berkley (WRB) in Q3 Earnings?
by Zacks Equity Research
W. R. Berkley's (WRB) third-quarter results are likely to reflect premium growth and improved expense ratio, partly offset by higher expenses and lower underwriting income.
Travelers (TRV) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Travelers' (TRV) third-quarter results are likely to reflect strength across its segments.
Progressive (PGR) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Progressive's (PGR) third quarter results likely to reflect better premiums and policies in force, partly offset by decline in investment income and higher expenses.
Allstate (ALL) on Track to Shed Its Life and Annuity Business
by Zacks Equity Research
Allstate (ALL) progresses well to get rid of its low-performing Life and Annuity business.
Reasons Why You Should Retain Arch Capital (ACGL) Stock
by Zacks Equity Research
Arch Capital (ACGL) is poised to grow on rate improvements, higher level of income on fund investments, and effective capital deployment.
Why ProAssurance (PRA) Stock Might be a Great Pick
by Zacks Equity Research
ProAssurance (PRA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
ProAssurance (PRA) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
ProAssurance (PRA) has been struggling lately, but the selling pressure may be coming to an end soon.
Earnings Estimates Rising for ProAssurance (PRA): Will It Gain?
by Zacks Equity Research
ProAssurance (PRA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Should You Add ProAssurance (PRA) to Your Portfolio?
by Zacks Equity Research
Riding high on its growing top line, strategic initiatives and solid second-quarter results, ProAssurance (PRA) holds enough potential to reap benefits for investors.
Top Ranked Momentum Stocks to Buy for August 23rd
by Zacks Equity Research
PRA, KSS, SKY, and TGH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 23, 2021.
ProAssurance's (PRA) Q2 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
ProAssurance's (PRA) Q2 results reflect better premiums and a solid contribution from its Segregated Portfolio and Specialty P&C Insurance segments.
ProAssurance (PRA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ProAssurance (PRA) delivered earnings and revenue surprises of 716.67% and 7.91%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
ProAssurance (PRA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
ProAssurance (PRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is ProAssurance (PRA) Down 8.7% Since Last Earnings Report?
by Zacks Equity Research
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Hold ProAssurance (PRA) in Your Portfolio?
by Zacks Equity Research
Backed by its balance sheet strength and strategic initiatives, ProAssurance (PRA) holds potential to reap benefits for investors.
ProAssurance (PRA) Concludes NORCAL Mutual Buyout for $441M
by Zacks Equity Research
ProAssurance (PRA) closes the pending NORCAL acquisition to boost its size and scale in the MPLI space.
ProAssurance's (PRA) Q1 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
ProAssurance's (PRA) Q1 results reflect reduced expenses, partly offset by lower premiums.